Background
Methods
Ethics statement
Patients and samples
Characteristic | NSCLC | MWA | Healthy |
---|---|---|---|
Number | 38 | 39 | 43 |
Gender | |||
Male | 19 | 20 | 22 |
Female | 19 | 19 | 21 |
Age (years) | |||
≥ 60 | 21 | 20 | 21 |
< 60 | 17 | 19 | 22 |
Stage | |||
IIIB | 10 | 13 | – |
IV | 28 | 26 | – |
Tumour location | |||
Peripheral | 38 | 39 | – |
Central | 0 | 0 | – |
Tumour size (cm) | |||
≥ 3.5 | 21 | 22 | – |
< 3.5 | 17 | 17 | – |
ECOG performance status | |||
0 | 0 | 2 | – |
1 | 36 | 35 | – |
2 | 2 | 2 | – |
Pathology | |||
Adenocarcinoma | 19 | 20 | – |
Squamous carcinoma | 13 | 10 | – |
Adenosquamous carcinoma | 6 | 8 | – |
Large cell carcinoma | 0 | 1 | – |
MWA time (min), mean (range) | – | 14.0 (4.0–42.0) | – |
MWA power | |||
70 | – | 33 | – |
60 | – | 6 | – |
Number of antennas | |||
One | – | 16 | – |
Two | – | 23 | – |
Serum preparation and 1H NMR spectroscopy
Data processing and multivariate analysis
Pathway analysis
Results
1H NMR spectra
No. | Metabolites | Chemical shifts (ppm) | NSCLC/CTRL | MWA/NSCLC | MWA/CTRL | |||
---|---|---|---|---|---|---|---|---|
fold |
p
| fold |
p
| fold |
p
| |||
1 | Isoleucine | 0.94 (t), 1.00 (d) | 1.09 | 1.18 | 1.29 | * | ||
2 | Leucine | 0.96 (d), 0.97 (d) | 1.09 | 0.93 | 1.00 | |||
3 | Valine | 0.99 (d), 1.05 (d) | 1.11 | 1.17 | 1.30 | ** | ||
4 | Isobutyrate | 1.07 (d) | 1.06 | 1.09 | 1.16 | |||
5 | Ethanol | 1.19 (d), 3.65 (q) | 1.01 | 1.11 | 1.12 | |||
6 | 3-Hydroxybutyrate | 1.20 (d), 2.30, 2.41 (m) | 1.15 | 1.09 | 1.25 | *** | ||
7 | Lactate | 1.33 (d), 4.12 (q) | 2.13 | *** | 0.90 | * | 1.92 | *** |
8 | Alanine | 1.48 (d), 3.78 (q) | 1.76 | *** | 0.87 | * | 1.52 | *** |
9 | Lysine | 1.73 (m), 1.91 (m), 3.30 (t) | 1.12 | 1.10 | 1.24 | *** | ||
10 | Acetate | 1.92 (s) | 1.18 | 1.08 | 1.27 | ** | ||
11 | Proline | 2.01 (m) | 1.45 | ** | 0.86 | 1.25 | ** | |
12 | Glycoprotein | 2.09 (s) | 1.18 | * | 0.89 | 1.05 | ||
13 | Glutamate | 2.05 (m), 2.12 (m), 2.36 (m) | 1.14 | ** | 0.85 | *** | 0.96 | |
14 | Glutamine | 2.14 (m), 2.45 (m) | 0.80 | *** | 1.11 | 0.89 | * | |
15 | Methionine | 2.14 (s), 2.65 (t) | 1.10 | 1.11 | 1.22 | * | ||
16 | Acetoacetate | 2.28 (s) | 1.15 | 1.19 | 1.37 | ** | ||
17 | Pyruvate | 2.38 (s) | 1.19 | 0.85 | 1.01 | |||
18 | Succinate | 2.41 (s) | 1.21 | 0.81 | 0.98 | |||
19 | Aspartate | 2.68, 2.81 (m) | 0.86 | 1.17 | 1.01 | |||
20 | Asparagine | 2.87, 2.95 (m) | 0.88 | 1.16 | 1.02 | |||
21 | Phosphocreatine | 3.04 (s), 3.93 (s) | 0.81 | *** | 1.13 | 0.91 | ||
22 | Choline | 3.20 (s) | 0.89 | 1.07 | 0.95 | |||
23 | O-Acetylcholine | 3.21 (s) | 0.89 | 0.89 | 0.79 | ** | ||
24 | O-Phosphocholine | 3.23 (s) | 0.89 | 0.86 | 0.76 | *** | ||
25 | TMAO | 3.27 (s) | 1.07 | 0.89 | 0.95 | |||
26 | Taurine | 3.27 (t), 3.42 (t) | 0.76 | *** | 1.38 | *** | 1.05 | |
27 | Glucose | 3.4–3.92 (m) | 0.92 | * | 1.08 | * | 0.99 | |
28 | Glycine | 3.56 (s) | 0.89 | * | 1.12 | * | 1.00 | |
29 | Threonine | 3.59 (d), 4.25 (m) | 0.82 | * | 1.20 | ** | 0.98 | |
30 | Glycerol | 3.58, 3.65 (m) | 1.24 | 0.82 | 1.01 | |||
31 | dCTP | 6.07 (d), 6.08 (t), 7.83 (d) | 0.86 | 0.86 | 0.74 | *** | ||
32 | Tyrosine | 6.91 (d), 7.20 (d) | 1.16 | ** | 0.97 | 1.12 | ** | |
33 | Phenylalanine | 7.33 (d), 7.38 (t), 7.43 (t) | 1.17 | * | 0.83 | 0.97 | ||
34 | Tryptophan | 7.55 (d), 7.74 (d) | 1.30 | *** | 0.89 | 1.15 | ** | |
35 | Histidine | 7.08 (s), 7.84 (s) | 0.88 | 1.14 | 1.00 | |||
36 | Tyramine | 7.24 (d) | 0.88 | 0.96 | 0.85 | ** | ||
37 | Formate | 8.46 (s) | 0.87 | 1.12 | 0.98 |